FOR IMMEDIATE RELEASE Contact: DEA Public Affairs (202) 307-7977 Press Release DEA releases 2018 National Drug Threat Assessment WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking
Read more →As the U.S. Surgeon General’s recent report on addiction highlights, the United States faces a serious opioid epidemic that shows no signs of abating.1 In 2015, more than 13 million Americans reported nonmedical use of opioids in the previous year, and about 2.5 million of those people have an opioid
Read more →
Two osteopathic addiction specialists explain how primary care physicians can help combat the opioid epidemic. By KATE SAMANO MONDAY, MARCH 6, 2017 Addiction specialists say colleagues in primary care receive little education to prepare them to care for patients with substance use disorders, which are life-long health conditions. Michael Levy,
Read more →For immediate release Contact DEA Public Affairs (202) 307-7977 Washington, DC – The Drug Enforcement Administration (DEA) today announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety. Mitragynine and
Read more →For Immediate Release AMERICAN BOARD OF MEDICAL SPECIALTIES RECOGNIZES THE NEW SUBSPECIALTY OF ADDICTION MEDICINE Landmark Event Expected to Significantly Increase Number of Physicians Trained to Prevent and Treat Addiction Bethesda, Maryland – March 14, 2015 – The American Board of Medical Specialties (ABMS) announced today the recognition of Addiction Medicine as
Read more →Dr. Levy was selected as one of the distinguished men of Nevada 2015
Read more →Michael S. Levy, D.O. re-appointed as Assistant Professor Family/Addiction Medicine.
Read more →After seeing the Sanjay Gupta CNN “Weed” specials, it is difficult to deny the benefits of medical cannabis to those children and their families suffering from unrelenting seizures, or that a British pharmaceutical company, GW Pharmaceuticals, has developed “Sativex” for spasms associated with multiple sclerosis and is currently in clinical
Read more →Over the past several years, advances in addiction treatment products have been developed to assist patients in their recovery programs from drugs of abuse and dependence. Drug Addiction Presently, three buprenorphine-based products are available for the treatment of opioid dependence. These include Suboxone, Zubsolv, and Bunavail. All of these preparations
Read more →Do you think legalizing marijuana for recreational use would increase the number of users? Not everyone including medical marijuana experts agree with the legalization of marijuana.
Read more →